Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cuprina Holdings (Cayman)CUPR -5.54%10 EV-to-OCF is -1.25 as of Jul. 14, 2026. GuruFocus rates CUPR with a GF Score™ of 10/100. The stock has 6 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Cuprina Holdings (Cayman) ranks better than 65.15% on this metric.
The historical rank and industry rank for Cuprina Holdings (Cayman)'s EV-to-OCF or its related term are showing as below:
CUPR'
s EV-to-OCF Range Over the Past 10 Years
Min: -195.29 Med: -15.84 Max: -0.44
Current: -1.25
During the past 5 years, the highest EV-to-OCF of Cuprina Holdings (Cayman) was -0.44. The lowest was -195.29. And the median was -15.84.
CUPR's EV-to-OCF is ranked better than 65.15% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 7.66
vs CUPR: -1.25
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cuprina Holdings (Cayman)'s PE Ratio (TTM) for today is calculated as:
Cuprina Holdings (Cayman)'s share price for today is $4.09.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cuprina Holdings (Cayman)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-1.420.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Cuprina Holdings (Cayman) EV-to-OCF Related Terms
Cuprina Holdings (Cayman) EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Cuprina Holdings (Cayman)'s EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cuprina Holdings (Cayman) EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cuprina Holdings (Cayman)'s EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Cuprina Holdings (Cayman)'s EV-to-OCF falls into.
Cuprina Holdings (Cayman)'s current Enterprise Value is $8.93 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cuprina Holdings (Cayman)'s Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $-7.12 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cuprina Holdings (Cayman) (CUPR) has a EV-to-OCF of -1.25 as of Jul. 14, 2026. According to the industry distribution chart, Cuprina Holdings (Cayman) ranks #298 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 34.9%.
Is Cuprina Holdings (Cayman)'s EV-to-OCF too high?
Cuprina Holdings (Cayman)'s current EV-to-OCF is -1.25. Based on the distribution chart, Cuprina Holdings (Cayman) ranks #298 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Cuprina Holdings (Cayman) has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Cuprina Holdings (Cayman)'s EV-to-OCF compare to BNGO and UEEC?
According to the Medical Devices & Instruments industry distribution chart, Cuprina Holdings (Cayman) ranks #298 out of 855 companies for EV-to-OCF. This puts Cuprina Holdings (Cayman) in the upper half of its industry. The industry median EV-to-OCF is 7.66. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.66, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cuprina Holdings (Cayman)'s current EV-to-OCF is -1.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cuprina Holdings (Cayman) stock overvalued right now?
Cuprina Holdings (Cayman) (CUPR) has a current EV-to-OCF of -1.25. The current EV-to-OCF is -1.25. Cuprina Holdings (Cayman)'s overall GF Score™ is 10/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Cuprina Holdings (Cayman) (CUPR), the current EV-to-OCF is -1.25 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.
10GF Score
Get the complete analysis for CUPR
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CUPR has been successfully added to your 
